Cargando…
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
INTRODUCTION: Honokiol, a small-molecule polyphenol isolated from magnolia species, is widely known for its therapeutic potential as an antiinflammatory, antithrombosis, and antioxidant agent, and more recently, for its protective function in the pathogenesis of carcinogenesis. In the present study,...
Autores principales: | Nagalingam, Arumugam, Arbiser, Jack L, Bonner, Michael Y, Saxena, Neeraj K, Sharma, Dipali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496153/ https://www.ncbi.nlm.nih.gov/pubmed/22353783 http://dx.doi.org/10.1186/bcr3128 |
Ejemplares similares
-
Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2017) -
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
por: Avtanski, Dimiter B., et al.
Publicado: (2015) -
Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment
por: Muniraj, Nethaji, et al.
Publicado: (2020) -
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
por: Avtanski, Dimiter B., et al.
Publicado: (2015) -
Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes
por: Xie, Bei, et al.
Publicado: (2017)